ABSTRACT. Carrier-mediated P-D-hydroxybutyrate transport in brush-border membrane (maternal-sided) vesicles prepared from trophoblast rat placenta was studied. The existence of a carrier-mediated transport system for B-D-hydroxybutyrate in brush-border membrane vesicles was substantiated by the strong inhibitory effect of the protein modifier p-chloromercuriphenyl sulfonic acid and by the saturability of P-D-hydroxybutyrate uptake as a function of @-D-hydroxybutyrate concentration. P-D-hydroxybutyrate uptake was stimulated by the presence of an inward-directed proton gradient but not by an inwarddirected Na+ gradient. The mechanism for transport of P-D-hydroxybutyrate seems to be a P-D-hydroxybutyrate/H+ symport and not a B-D-hydroxybutyrate/OH-antiport because P-D-hydroxybutyrate transport was not sensitive to 4,4-diisothiocyano-2,2'-stilbenedisulfonic acid or furosemide. The Km, V, , , , and k,, calculated by applying the iteration procedure to the data were 16 mM, 58 nmol. mg-'
hydroxybutyrate transport system might be shared by other monocarboxylic acids, and the carrier shows reversibility and exchange properties. There were no significant changes in the kinetic parameters of the 8-D-hydroxybutyrate transport system during the last 3 d of gestation. Nevertheless, there was a significant increase in the capacity of the P-D-hydroxybutyrate transport system in brushborder membrane vesicles prepared from fasted pregnant rats, suggesting that the rise in maternal ketone body levels occurring as a consequence of maternal starvation is concurrent with the stimulation of the activity of the 8-Dhydroxybutyrate placental carrier to supply the fetus with ketone bodies. The signal mediating the stimulation of carrier activity due to starvation remains to be elucidated. (Pediatr Res 32: 317-323,1992) Abbreviations BBMV, brush-border membrane vesicles Tris, 2-amino-2-hydroxymethylpropane-1,3-diol Mes, 2-(N-morpho1ino)-ethanesulfonic acid p-CMBS, p-chloromercuriphenylsulfonic acid FCCP, carbonylcyanide p-trifluoromethoxyphenylhydrazone DIDS, 4,4'-diisothiocyano-2,2'-stilbenedisulfonic acid SH, sulfhydril pHin, intravesicular pH pHout, extravesicular pH Ketone bodies are used by both the placenta and the fetus for the synthesis of lipids and as a source of energy (1-3). However, ketone bodies are synthesized by maternal liver because ketogenesis is not active in fetal liver during gestation (4) . The levels of circulating fatty acids increase in maternal blood during late gestation, this being associated with high concentrations of ketone bodies in maternal and fetal blood. Thus, fatty acids are converted into ketone bodies in the maternal liver, from which they are transferred to the fetus across the placenta. Once in the fetus, ketone bodies can be transformed into lipids or amino acids (3) or oxidized to COz for energy production (1). Moreover, ketone bodies seem to be preferred to other relevant substrates because high levels of P-D-hydroxybutyrate may inhibit the oxidation of glucose or lactate in the fetal brain (3) (4) (5) (6) (7) .
The concentrations of ketone bodies in the mother and fetus are related, there being a concentration gradient from the mother to the fetus that may induce transference in that sense (1, 8) . Because P-D-hydroxybutyrate has an ionization constant of 4.4, it is negatively charged at physiologic pH, thereby hindering its diffusion across the membrane. Consequently, the occurrence of a specific transporter for P-D-hydroxybutyrate would allow the supply of this substrate at rates far higher than those foreseen for simple diffusion. Mediated transfer mechanisms for ketone bodies in liver, kidney, erythrocytes, thymocytes, and blood-brain barrier have been described (9) (10) (11) (12) . The existence of a mediated transfer mechanism for ketone bodies across the placenta may be especially relevant in situations such as maternal fasting, the ingestion of fat-rich diets, or uncontrolled diabetes. Under these circumstances, the maternal plasma concentrations of ketone bodies are highly increased, resulting in a parallel increase in the fetal concentration of ketone bodies (1 3).
The aim of the present study was to determine the existence of a specific transport mechanism for P-D-hydroxybutyrate in rat placenta BBMV. The effect of gestational age and maternal fasting on the kinetic parameters of P-D-hydroxybutyrate were also examined.
MATERIAL AND METHODS

Reagents. P-D-[3-14C]-hydroxybutyric acid was purchased from
New England Nuclear (Itisa, Madrid, Spain). P-D-and P-Lhydroxybutyric acid were purchased from Serva (Heidelberg, Germany). L-Lactic acid, pyruvate, phenylmethylsulfonylfluoride, and BSA (Fraction V) were purchased from Sigma Chemical Co. (St. Louis, MO). FCCR was obtained from Aldrich (Steinheim, Germany). All other reagents were of analytical grade.
Preparation of microvillous membranes. Microvillous membranes from rat placenta were prepared by the method of Alonso de la Torre et al. (14) , essentially based on that reported by Smith et al. (1 5) but modified by including two steps involving precipitation of the vesicles with MgCL. Briefly, the procedure was as follows. Albino Wistar rats, of known gestational age (19.5,20.5, TORRE ET A L and 21.5 d) fed on stock laboratory diet (carbohydrate 58.7%, protein 17.0%, fat 3.0%, and added salts and vitamins) were used for the experiments. Females with a mean weight of 250 g were caged with males overnight, and conception was confirmed the following morning by the presence of spermatozoa in vaginal smears. Pregnant rats were killed by cervical dislocation, the fetal-placental units were removed, and the fetuses were weighed as further control of gestational age. Each placenta was perfused with cold, low-calcium Krebs-Henseleit buffer (pH 7.4) (1 6) until the placenta appeared free of blood. All subsequent steps were then carried out at 4°C. The maternal layer of each placenta was peeled off and the remaining labyrinthine tissue was washed once in cold Krebs-Henseleit buffer (pH 7.4). The placentas were rinsed three times with 100 mM calcium chloride solution, weighed, and used immediately. The tissue was minced in buffer A (500 mM sorbitol, 1 mM EGTA, 0.1 mM phenylmethylsulfonylfluoride, and 20 mM Tris/Mes; pH 7.4) and homogenized by applying 10 up-down strokes of a motor-driven Teflon glass homogenizer (S-778; B. Braun, Melsungen, Germany). The homogenate was then made up to 10 times the tissue weight with additional buffer A. MgC12 was added to a final concentration of 10 mM, and after 30 rnin standing the homogenate was centrifuged at 800 x g for 10 rnin using a Beckman L8-M centrifuge (Beckman Instruments Espaiia, Madrid, Spain). This yielded a pellet (P 1) and a supernatant (S 1). P 1 was washed with five times the weight of the placenta with buffer A and homogenized with eight up-down strokes of the motor-driven Teflon homogenizer. After addition of MgCL to a final concentration of 10 mM, the suspension was allowed to stand for 15 min. The washed PI was centrifuged at 800 x g for 10 min, resulting in another pellet, which was discarded, and a supernatant (S 1 '). Supernatants S 1 and S1' were pooled together and centrifuged at 10 400 x g for 20 min. The resulting pellet (P2) was discarded, and the supernatant (S2) was centrifuged at 110 000 x g for 45 min using a Beckman L8-M ultracentrifuge. The final supernatant (S3) was discarded, and the cream-colored pellet (P3) was resuspended in a small volume of buffer B (500 mM sorbitol and 20 mM Tris/ Mes; pH 7.4) and homogenized six times through a 25-gauge hypodermic needle. The BBMV preparation from rat placenta showed a degree of alkaline phosphatase enrichment seven times greater than that of the placental tissue homogenate. A similar method has been recently reported by Glazier et al. (17) , although apparently a better purification was reached as judged by the higher enrichment in alkaline phosphatase observed in their preparations.
Membrane integrity of our BBMV was sustained by the constancy of the apparent intravesicular space for P-~-[3-'~C]-hydroxybutyric acid in vesicle batches (1.34 k 0.13 pL/mg; n = 20). Alkaline phosphatase activity was similar in intact or Triton X-100-disrupted preparations, suggesting that our vesicles are right-side-out oriented.
Rat membrane vesicles were adjusted to about 15 mg of protein/mL and stored in liquid nitrogen until use. To obtain vesicles preloaded with certain ions or substrates, two distinct procedures were used with similar results, namely, entrapment during vesicle formation or application of two cycles of freezing and thawing in the presence of the desired solution.
Enzyme assays. The microvillous membrane vesicle preparation was tested for enrichment in apical plasma membrane and for contamination by basal plasma membrane by analyzing the activity of the following marker enzymes: alkaline phosphatase (EC 3.13.1) (18) and Na+-K+ ATPase (EC 3.6.1.37) (19) . Na+-K+ ATPase activity was determined on the day that the membrane fractions were prepared. The degrees of enrichment of the markers were 6 and 0.5, respectively. Alkaline phosphatase determination was carried out after shortage at -80°C. Protein concentration was measured by a modification of the Lowry procedure (20) with serum albumin as standard.
Uptake assays. P-D-[3-'4C]-hydroxybutyric acid uptake by microvillous membrane vesicles was determined using a rapid filtration technique as described by Hopfer et al. (21) . For most experiments, incubations at 37°C were started by mixing 10 pL of the vesicle preparation in buffer B with 90 pL of buffer B with 14C labeled P-D-hydroxybutyrate adjusted to pH 6.0 to 7.4. All experiments were performed with the same inward-directed net osmotic gradient (500/600 in/out). Incubations were stopped with 4 mL of ice-cold stop solution containing 20 mM Tris-Mes buffer, 350 mM KCl, and 25 mM MgS04. The diluted samples were rapidly filtered under a negative pressure through wetted cellulose-nitrate filters (0.65-pm pore; Millipore Ibirica, Madrid, Spain), which were then rinsed four times with 4 mL of stop solution. The entire procedure lasted less than 15 s. Appropriate blanks were made to correct for nonspecific marker retention on the filters. After dissolving the filters in 4 mL of scintillation fluid (Ready Safe, Beckman), radioactivity was measured in a scintillation spectrophotometer. Uptake buffers were prepared at different pH values by adding Tris or Mes but keeping the sum of Tris and Mes concentrations equal to 20 mM. The exact composition of the uptake buffers and preloading buffers is specified in the figure legends and table footnotes.
Fitting of transport results to Michaelis-Menten equation.
Absolute velocity data as a function of the substrate concentration were fitted by iteration to a complex equation involving the sum of one nonsaturable and one saturable component (22, 23) . The iteration method allows the estimation of V, , , and Km and avoids the error subsequent to working at very high substrate concentrations.
Expression of results. Statistical analyses. Statistical analyses were carried out with t test. Saturation curves were solved by applying nonlinear regression analysis that includes an F test (22) . All the calculations were performed with an Apple Macintosh SE microcomputer.
RESULTS
Effect of p-CMBS on P-~hydroxybutyrate uptake.
The existence of a carrier-mediated protein with SH functional groups involved in monocarboxylic acid transport across different epithelia has been deduced from the inhibitory effect of specific modifiers of SH groups of proteins (25) (26) (27) (28) . One mM P-Dhydroxybutyrate uptake in BBMV preincubated for 45 rnin at 25°C with 0.55 mM p-CMBS, a nonpermeable organomercurial mercapeptide bond reagent (29) , decreased by approximately 50% as compared with control values (2.1 f 0.15 versus 5.2 +-0.14 nmol.mg-'. 10 s-I in controls). The specific inhibitory action of p-CMBS on P-D-hydroxybutyrate uptake is substantiated by the fact that the sole presence of 0.55 mM p-CMBS without preincubation did not modify the P-D-hydroxybutyrate uptake level as compared with controls. These results suggest the involvement of SH groups of a protein in P-D-hydroxybutyrate uptake across BBMV from trophoblast rat placenta.
Effect of extravesicular pH on p-~hydroxybutyrate uptake. The effect of variations in extravesicular pH on the transport of 1 mM 0-D-hydroxybutyrate in BBMV from trophoblast rat placenta is shown in Figure 1 . In these experiments extravesicular pH ranged from 5.2 to 8.2 and the intravesicular pH was constant and fixed at 7.4. The results show that acidification of the incubation medium induces a significant increase in the 0-Dhydroxybutyrate uptake rate (Fig. I ), suggesting that P-D-hydroxybutyrate uptake in 3BMV is presumably driven by a coupled proton gradient.
Effect of inward-directed H+ gradient on P-~hydroxybutyrate uptake. The effect of variations in the magnitude of the pH gradient on P-D-hydroxybutyrate uptake across the BBMV is shown in Figure 2 . These findings show that in the presence of an inward-directed proton gradient (pHin = 7.41pHout = 5.4) 1 mM P-D-hydroxybutyrate uptake was rapid and a transient accumulation "overshoot" was observed. i.e. 10-fold higher uvtake at 10 s than at equilibrium. A lower transmembrane ; H grabient (pHin = 7.41pHout = 6.0) was associated with a slow initial uptake rate and with a small transient accumulation (5-fold higher uptake at 10 s than at the equilibrium). In the absence of an inward-directed proton gradient (pHin = 7.41pHout = 7.4 or pHin = 6.01pHout = 6.0), no overshoot was observed (Fig. 2) . These results lent further support to the notion that P-D-hydroxybutyrate is taken up in BBMV from rat placenta by a mechanism in which the proton gradient provides the driving force for an uphill accumulation.
Effect of inward-directed Nu+ gradient. To quantify the contribution of an inside-diffusion potential generated by cations on P-D-hydroxybutyrate uptake across BBMV from rat placenta, we investigated the effect of different magnitudes of an inwarddirected Naf gradient on 1 mM P-D-hydroxybutyrate uptake in the presence (pHin = 7.41pHout = 6.0) or absence (pHin = 7.41 pHout = 7.4) of a proton gradient. Figure 3 illustrates P-Dhydroxybutyrate uptake when Naf gradients of different magnitudes, were established. No significant increase in the initial uptake rate was observed either in the presence or in the absence of a proton gradient when inwardly directed Na' gradients of different magnitude were imposed. These results rule out the involvement of an Na+ gradient as the driving force of P-Dhydroxybutyrate uptake in BBMV from rat placenta. Effect of FCCP on P-~hydroxybutyrate uptake. The stimulatory effect of a proton gradient on P-D-hydroxybutyrate uptake across BBMV could be due to the generation of an inside-positive diffusion membrane potential that would favor the influx of charged P-D-hydroxybutyrate. To discard such an effect, we investigated the effect of the protonophore FCCP (100 pM) on 1 mM P-D-hydroxybutyrate uptake in the presence and absence of a pH gradient. As shown in Figure 4 , P-D-hydroxybutyrate uptake was significantly inhibited by FCCP in the presence of an inward-directed proton gradient but was unaffected in the absence of a proton gradient. This suggests that FCCP did not generate an inside-positive membrane potential, instead, the protonophore would act by dissipating a proton gradient. Consequently, this result is consistent with the idea that an Hf gradient is the driving force of the electroneutral transport of P-D-hydroxybutyrate in BBMV from rat placenta.
Effect ofDIDS and furosemide on P-~hydroxybutyrate uptake. To further distinguish whether @-D-hydroxybutyrate uptake is accomplished in BBMV by a symport mechanism (P-D-hydroxybutyrate/Hf) or by an antiport mechanism (P-D-hydroxybutyrate/OH-), we camed out experiments testing the effect of 0.5 mM DIDS or furosemide, specific inhibitors of anion exchangers, on 1 mM P-D-hydroxybutyrate uptake in the presence of a proton gradient. The data indicated that P-D-hydroxybutyrate uptake is insensitive to either DIDS or furosemide (4. cotransport system coupled to a proton gradient. These findings support the previous observations that the proton gradient is the driving force for an electroneutral P-D-hydroxybutyrate/Hf symport.
Kinetics of P-~hydroxybutyrate uptake. The concentration dependence of P-D-hydroxybutyrate was examined at 37°C for 10 s in the presence of an inward-directed proton gradient (pHin = 7.41pHout = 6.0). Figure 5 shows that P-D-hydroxybutyrate uptake is saturable at high concentrations of substrate. Total uptake rates were fitted by nonlinear regression to an equation with two terms, one saturable and one nonsaturable (diffusion): The inset shows Eadie-Hofstee analysis of the experimental data represented in Figure 5 . The linear plot obtained confirms the involvement of only one transport system for P-D-hydroxybutyrate uptake in BBMV from rat placenta. From these results, it may be inferred that P-D-hydroxybutyrate uptake in BBMV is accomplished by a transport system with very low afinity.
Trans-stimulation of P-~hydroxybutyrate uptake. One mM P-D-hydroxybutyrate uptake was studied at 37°C for 10 s in BBMV preloaded with 10 mM P-D-hydroxybutyrate, L-lactate, or pyruvate either in the presence (pHin = 7.4/pHout = 6.0) or absence (pHin = 7.4/pHout = 7.4) of an inward-directed proton gradient. The monocarboxylic acids inside vesicles significantly stimulated P-D-hydroxybutyrate uptake both in the presence and absence of a proton gradient (Table 1) . Taken together, these results might suggest the existence of a general monocarboxylic acid transport system with exchange properties in BBMV from trophoblast rat placenta.
Inhibition of P-~hydroxybutyrate uptake by other monocarboxylic acids. To characterize the stereospecificity of the P-Dhydroxybutyrate transport system, we examined the inhibitory effect of several monocarboxylic acids, namely P-D-hydroxybutyrate P-L-hydroxybutyrate, L-lactate, and pyruvate on 1 mM 0-D-hydroxybutyrate uptake at 37°C for 10 s ( Table 2 ). The presence of these monocarboxylic acids on the cis side of the membrane strongly inhibits P-D-hydroxybutyrate uptake. These results reinforced the suggestion of the existence of a common canier for monocarboxylic acids in BBMV from rat placenta trophoblast. The observed inhibition of P-D-hydroxybutyrate uptake by P-L-hydroxybutyrate points to the low stereospecificity of the carrier. Effect of gestational age on P-~hydroxybutyrate transport system. The concentration dependence of P-D-hydroxybutyrate uptake in BBMV from trophoblast rat placenta at 19.5, 20.5, and 21.5 d of gestation is shown in Figure 6 . These results show that during the last 3 d of gestation there were no changes in the kinetic parameters of the P-D-hydroxybutyrate transport system due to development (Table 3) . Table 1 . Trans-stimulation of P-~hydroxybutyrate uptake by preloading vesicles with unlabeled L-lactate, pyruvate, or Phydroxybutyrate* Percentages were calculated taking each corresponding control as 100%. Table 2 . Inhibitory effect of monocarboxylates on P-D hydroxybutyrate uptake by BBMVfrom rat placenta* Efect of maternal fasting on P-~hydroxybutyrate uptake. Because the placenta plays a regulatory role in the maternofetal transfer of substrates, we investigated the effect of maternal fasting (48 h) on the kinetic parameters of P-D-hydroxybutyrate carrier in BBMV from trophoblast rat placenta. The concentration dependence plot of P-D-hydroxybutyrate uptake in BBMV prepared from placenta of 48-h fasted rats (Fig. 7) shows a significant increase in V, , , (Table 3) as compared with that from unstarved mothers. These results show that the capacity of P-Dhydroxybutyrate carrier increases as a consequence of maternal starvation without changes in its affinity.
DISCUSSION
The sensitivity of P-D-hydroxybutyrate uptake to SH-protein reagents suggests that the transport of P-D-hydroxybutyrate through brush-border membrane of rat placenta is mediated by a protein (25-28) that collaborates in the translocation of P-Dhydroxybutyrate through the membrane of the maternal side of the placenta. The transport of P-D-hydroxybutyrate is not dependent on an Na+ gradient (Fig. 3 ) but rather is driven by an inwardly directed proton gradient ( Figs. 1 and 2) . The possibility of a proton gradient being the driving force for P-D-hydroxybutyrate transport was reinforced by the fact that dissipation of the proton gradient by the presence of FCCP (Fig. 4) inhibited P-Dhydroxybutyrate transport. In addition, the inhibition caused by FCCP (Fig. 4) but not by DIDS or furosemide suggests that P-Dhydroxybutyrate is transported by a P-D-hydroxybutyrate/H+ symport mechanism rather than by a P-D-hydroxybutyratel0H-antiporter. A similar proton-coupled mechanism for P-D-hydroxybutyrate transport has been described in thymocytes, erythrocytes, and dissociated cells from rat brain (12, 28) .
Nonlinear regression analysis of the concentration-dependent kinetics of p-D-hydroxybutyrate uptake shows that the diffusional component of the passage of P-D-hydroxybutyrate through the maternal-sided placental membrane is negligible, suggesting that most P-D-hydroxybutyrate uptake is carried out by a mediated mechanism. Moreover, the linearity of the Eadie-Hofstee (Fig.   5 ) plot suggests that carrier-mediated P-D-hydroxybutyrate transport through BBMV is accomplished by a single mechanism. The Km value observed in our experiments is similar to that found in erythrocytes (1 2) and blood-brain barrier (1 1) but higher than that found in dissociated brain cells (28) . Ketone body concentrations in maternal blood (13, 30, 31) are much lower than the Km observed in our experiments, suggesting that P-Dhydroxybutyrate transport through BBMV is permanently dependent on its maternal concentration. This low-affinity mechanism would prevent saturation of the carrier at physiologic concentrations of ketone bodies. This may be the case in maternal starvation, in which the V, , , of the carrier increases without changes in Km (Fig. 7) . These changes coincide with the enhancement of plasma concentrations of ketone bodies in the mother (1 3, 30, 3 1) . This may provide ketone bodies to the fetus as an alternative fuel to glucose during maternal starvation, in fact, during late gestation fetal ketogenesis is not induced (4), which is consistent with the idea that ketone bodies are supplied by the mother to the fetus to continue its development even though the glucose supply is restricted. It should be mentioned that ketone bodies are synthesized by the mother from her own reserves, allowing a supply of metabolic fuels to the fetus without relying on exogenous nutrients. it is not surprising that during the suckling period, when the blood-brain barrier finally substitutes the placenta in the control of selective substrate supply to the brain, P-D-hydroxybutyrate transport through the bloodbrain barrier is also stimulated by starvation (32, 33) . However, the low specificity of the carrier (Table 2) together with its possible reversibility (Table 1) suggest that @-D-hydroxybutyrate shares a common carrier-mediated mechanism with other monocarboxylic acids. In this sense, kinetic parameters similar to those of the (3-D-hydroxybutyrate carrier (Table 3) have been reported for lactate transport across human (34, 35) and rat (14) placental membranes, a fact consistent with the idea that a common carrier may be responsible for the transport of monocarboxylic acid across placental membranes. This may explain our results, in which the kinetic parameters of the carrier did not change during late gestation (Fig. 6 ) because a carrier used by different monocarboxylates would not be expected to be sensitive to development; if this were so, it would not be able to fulfill the requirements of each particular substrate. Nevertheless, ketone bodies may be the major substrates transported by this carrier because of the importance of these substrates in fetal development, particularly during maternal fasting. In fact, maternal blood ketone body concentrations increased 100-fold because of starvation, whereas the concentrations of other putative substrates of this carrier, such as lactate or pyruvate, were maintained in these circumstances (3 1). Whether the increase in ketone body transport through placental membranes caused by starvation is associated with concurrent enhancement of maternal ketogenesis by a common signal for both processes remains to be elucidated.
